---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-030613"
form_type: "8-K"
ticker: "ABBV"
cik: "0001551152"
company_name: "AbbVie Inc."
filed_at: "2022-03-04T23:59:59+00:00"
generated_at: "2026-06-27T01:34:27.743497+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Director Edward M. Liddy to retire at AbbVie 2022 annual meeting in May

## Summary
- Edward M. Liddy informed AbbVie on Feb 28, 2022 of his decision to retire as director.
- Retirement effective as of the 2022 annual shareholders meeting in May.
- No replacement named; board will address vacancy in due course.

## SEC filing metadata
- accession: 0001104659-22-030613
- form_type: 8-K
- ticker: ABBV
- cik: 0001551152
- company_name: AbbVie Inc.
- filed_at: 2022-03-04T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1551152/000110465922030613/0001104659-22-030613-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1551152/000110465922030613/tm228136d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-030613
- JSON: https://secwatch.observer/filing/0001104659-22-030613.json
- Plain text: https://secwatch.observer/filing/0001104659-22-030613.txt

## Key facts
- Executive change
  Edward M. Liddy retired as director at AbbVie Inc..
  - Action: retired
  - Role: director
  source text: Edward M. Liddy informed AbbVie Inc. of his decision to retire as a director as of the 2022 annual shareholders meeting in May.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1551152/000110465922030613/0001104659-22-030613-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.